Determinants of imminent fracture risk in postmenopausal women with osteoporosis
2020 · Osteoporosis International · 163 citations
https://doi.org/10.1007/s00198-020-05294-3
R
Rich Barron
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
1.9K
Citations
23
h-index
30
i10-index
Rich Barron is an academic researcher from Amgen (United States). The author has contributed to research in topics: Neutropenia and Cancer Infections & Blood disorders and treatments & Bone health and osteoporosis research. The author has an h-index of 23, co-authored 45 publications.
Papers by this author
worksHospitalizations for osteoporosis-related fractures: Economic costs and clinical outcomes
2016 · Bone Reports · 111 citations
https://doi.org/10.1016/j.bonr.2016.07.005
Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data
2016 · Archives of Osteoporosis · 100 citations
https://doi.org/10.1007/s11657-016-0280-5
Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fractures
2017 · Osteoporosis International · 48 citations
https://doi.org/10.1007/s00198-017-4103-3
Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis
2014 · BMC Health Services Research · 43 citations
https://doi.org/10.1186/1472-6963-14-189
Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice
2015 · Supportive Care in Cancer · 14 citations
https://doi.org/10.1007/s00520-015-3039-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat